Investors may have been provided a unique opportunity to take advantage of an under-the-radar value opportunity. SANUWAVE’s (OTCMKTS: SNWV) planned acquisition of Celularity’s UltraMIST® Ultrasound Healing Therapy has gone relatively unnoticed by investors despite the agreement being a potentially transformative event to the company. The deal immediately brings revenue-generating assets to SANUWAVE, including more than 900 […]
